Plus Therapeutics (PSTV) Goodwill & Intangibles (2010 - 2026)
Plus Therapeutics (PSTV) reported Goodwill & Intangibles of $671000.0 for Q1 2026, down 16.85% year-over-year from $807000.0 in Q1 2025, and down 4.82% quarter-over-quarter from $705000.0 in Q4 2025.
Plus Therapeutics (PSTV) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Goodwill & Intangibles data on file, last reported at $671000.0 in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $671000.0, down 16.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $671000.0 (down 16.85% YoY), and the FY2025 annual result was $705000.0, down 16.17% from the prior year.
- Goodwill & Intangibles fell to $671000.0 in Q1 2026 per PSTV's latest filing, from $705000.0 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $929000.0 in Q2 2024 and troughed at $405000.0 in Q1 2024.
- A 5-year average of $615294.1 and a median of $522000.0 in 2022 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles jumped 113.07% in 2024, then slipped 16.85% in 2026.
- A 5-year view of Goodwill & Intangibles shows it stood at $466000.0 in 2022, then dropped by 11.16% to $414000.0 in 2023, then jumped by 103.14% to $841000.0 in 2024, then fell by 16.17% to $705000.0 in 2025, then fell by 4.82% to $671000.0 in 2026.
- Business Quant data shows PSTV's Goodwill & Intangibles at $671000.0 in Q1 2026, $705000.0 in Q4 2025, and $746000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 671,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Sep 30, 2025 | 746,000.00 |
| Jun 30, 2025 | 773,000.00 |
| Mar 31, 2025 | 807,000.00 |
| Dec 31, 2024 | 841,000.00 |
| Sep 30, 2024 | 885,000.00 |
| Jun 30, 2024 | 929,000.00 |
| Mar 31, 2024 | 405,000.00 |
| Dec 31, 2023 | 414,000.00 |
| Sep 30, 2023 | 421,000.00 |
| Jun 30, 2023 | 436,000.00 |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Sep 30, 2022 | 485,000.00 |
| Jun 30, 2022 | 503,000.00 |
| Mar 31, 2022 | 522,000.00 |
| Dec 31, 2021 | 423,000.00 |
| Sep 30, 2021 | 432,000.00 |
| Jun 30, 2021 | 441,000.00 |